A nurse is evaluating teaching on a client who has a new prescription for Montelukast to treat asthma. Which of the following statements by the client indicates an understanding of the teaching?

A. "I'll use a spacer device when I inhale this medication.": Montelukast is not an inhaled medication; it is taken orally in tablet or chewable form. Spacer devices are used with inhalers to improve drug delivery to the lungs, which is not applicable to Montelukast. B. "I'll rinse my mouth after taking this medication.": Rinsing the mouth is advised after using inhaled corticosteroids to reduce the risk of oral candidiasis. Since Montelukast is taken by mouth and is not associated with this risk, rinsing is unnecessary. C. "I'll take this medication when I get an asthma attack.": Montelukast is not a rescue medication. It is a leukotriene receptor antagonist used for long-term control and prevention of asthma symptoms. It has no role in managing acute bronchospasm. D. "I'll take this medication once a day in the evening.": Montelukast is typically taken once daily in the evening, especially in patients with nocturnal asthma or exercise-induced symptoms. Evening dosing enhances its effectiveness in controlling nighttime symptoms and reducing airway inflammation.